AbbVie Inc. (ABBV)
A+
Pipeline Grade
Financial Position (from SEC Filings)
$9,391.0M
Cash & Equivalents
$3,829.0M
Quarterly Burn Rate
$438,306M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (83 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
ELAGOLIX SODIUM
ORILISSA |
APPROVED | — |
|
BRIMONIDINE TARTRATE, TIMOLOL MALEATE
COMBIGAN |
APPROVED | — |
|
FOSCARBIDOPA, FOSLEVODOPA
VYALEV |
APPROVED | — |
|
PARICALCITOL
ZEMPLAR |
APPROVED | — |
|
GATIFLOXACIN
ZYMAXID |
APPROVED | — |
|
UBROGEPANT
UBRELVY |
APPROVED | — |
|
BRIMONIDINE TARTRATE
ALPHAGAN P |
APPROVED | — |
|
CITALOPRAM HYDROBROMIDE
CELEXA |
APPROVED | — |
|
VILAZODONE HYDROCHLORIDE
VIIBRYD |
APPROVED | — |
|
BIMATOPROST
DURYSTA |
APPROVED | — |
|
FLUOROMETHOLONE
FML |
APPROVED | Acute Disseminated Encephalomyelitis, Acute Myeloid Leukemia, Adenocarcinoma, Advanced Breast Cancer, Age Related Macular Degeneration, Age Related Macular Degeneration (AMD), Anti-AMPAR-1/2 Associated Autoimmune Encephalitis, Anti-CASPR-2 Associated Autoimmune Encephalitis, Anti-GABAR-1/2 Associated Autoimmune Encephalitis, Anti-GAD65 Associated Autoimmune Encephalitis, Anti-Lgi-1 Associated Autoimmune Encephalitis, Anti-NMDAR Encephalitis, Asthma, Breast Cancer, Breast Cancer Recurrent, Cancer, Carcinoma, Carcinoma, Renal Cell, Chronic Idiopathic Urticaria, Chronic Myeloid Leukemia, Chronic Spontaneous Urticaria, Chronic Urticaria, Clear-cell Metastatic Renal Cell Carcinoma, CNS Lupus, CNS Sarcoidosis, CNS Vasculitis, COVID-19, Ewing's Sarcoma, Failure of Exactly One Prior VEGF-targeted Therapy, Fallopian Tube Neoplasms, Hashimoto Encephalitis, HER 2 Negative Breast Cancer, Her2-negative Locally Advanced Breast Cancer, Her2-negative Metastatic Breast Cancer, HER2/Neu-negative Carcinoma of Breast, High-grade |
|
ELUXADOLINE
VIBERZI |
APPROVED | — |
|
VENETOCLAX
VENCLEXTA |
APPROVED | — |
|
PANCRELIPASE (AMYLASE, LIPASE, PROTEASE)
CREON |
APPROVED | — |
|
LOPINAVIR, RITONAVIR
KALETRA |
APPROVED | — |
|
SEVOFLURANE
ULTANE |
APPROVED | — |
|
SUCRALFATE
CARAFATE |
APPROVED | — |
|
CEFTAROLINE FOSAMIL
TEFLARO |
APPROVED | — |
|
DALBAVANCIN HYDROCHLORIDE
DALVANCE |
APPROVED | — |
|
AVIBACTAM SODIUM, AZTREONAM
EMBLAVEO |
APPROVED | — |
|
LEVOMILNACIPRAN HYDROCHLORIDE
FETZIMA |
APPROVED | — |
|
AVIBACTAM SODIUM, CEFTAZIDIME
AVYCAZ |
APPROVED | — |
|
ATOGEPANT
QULIPTA |
APPROVED | — |
|
MILNACIPRAN HYDROCHLORIDE
SAVELLA |
APPROVED | — |
|
KETOROLAC TROMETHAMINE
ACULAR LS |
APPROVED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Amyotrophic Lateral Sclerosis, Chronic Kidney Disease, Chronic Low Back Pain, COVID-19, Disorder Related to Renal Transplantation, Endothelial Dysfunction, Growth Hormone-Deficiency, Healthy Volunteers, Insomnia, Myelodysplastic Syndromes, Osteoarthritis, Osteoarthritis |
|
CARIPRAZINE HYDROCHLORIDE
VRAYLAR |
APPROVED | — |
|
BERACTANT
SURVANTA |
APPROVED | — |
|
ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE, ELAGOLIX SODIUM
ORIAHNN (COPACKAGED) |
APPROVED | — |
|
PREDNISOLONE ACETATE
PRED MILD |
APPROVED | — |
|
ASENAPINE MALEATE
SAPHRIS |
APPROVED | — |
|
UPADACITINIB
RINVOQ |
APPROVED | — |
|
GLECAPREVIR, PIBRENTASVIR
MAVYRET |
APPROVED | — |
|
DEOXYCHOLIC ACID
KYBELLA |
APPROVED | — |
|
LINACLOTIDE
LINZESS |
APPROVED | — |
|
DESERPIDINE, HYDROCHLOROTHIAZIDE
ORETICYL FORTE |
NDA | — |
|
SULFOXONE SODIUM
DIASONE SODIUM |
NDA | — |
|
ATROPINE SULFATE, MEPERIDINE HYDROCHLORIDE
ATROPINE AND DEMEROL |
NDA | — |
|
DARIFENACIN HYDROBROMIDE
ENABLEX |
NDA | — |
|
DEXTROTHYROXINE SODIUM
CHOLOXIN |
NDA | — |
|
EPROSARTAN MESYLATE, HYDROCHLOROTHIAZIDE
TEVETEN HCT |
NDA | — |
|
TRIMETHADIONE
TRIDIONE |
NDA | — |
|
CISATRACURIUM BESYLATE
NIMBEX |
NDA | — |
|
EPROSARTAN MESYLATE
TEVETEN |
NDA | — |
|
DOXACURIUM CHLORIDE
NUROMAX |
NDA | — |
|
ETHCHLORVYNOL
PLACIDYL |
NDA | — |
|
PARAMETHADIONE
PARADIONE |
NDA | — |
|
SULFADIAZINE
SULFADIAZINE |
NDA | Acute Coronary Syndrome, Acute Coronary Syndromes, Anemia, Sickle Cell, Benign Prostatic Hyperplasia, Coronary Artery Disease, Coronary Artery Disease (CAD), COVID-19, Healthy, Myocardial Infarction, Neoplasms, Pancreatic Cancer, SARS-CoV2 |
|
DICUMAROL
DICUMAROL |
NDA | Acute Coronary Syndrome, Acute Coronary Syndromes, Anemia, Sickle Cell, Benign Prostatic Hyperplasia, Coronary Artery Disease, Coronary Artery Disease (CAD), COVID-19, Healthy, Myocardial Infarction, Neoplasms, Pancreatic Cancer, SARS-CoV2 |
|
URSODIOL
URSO FORTE |
NDA | — |
|
CEFDINIR
OMNICEF |
NDA | — |
|
VALPROIC ACID
DEPAKENE |
NDA | — |
|
DICYCLOMINE HYDROCHLORIDE
BENTYL PRESERVATIVE FREE |
NDA | — |
|
ISOPROTERENOL SULFATE
NORISODRINE |
NDA | — |
|
ESCITALOPRAM OXALATE
LEXAPRO |
NDA | — |
|
METHYCLOTHIAZIDE
ENDURON |
NDA | — |
|
NIACIN
NIASPAN |
NDA | — |
|
NEBIVOLOL HYDROCHLORIDE, VALSARTAN
BYVALSON |
NDA | — |
|
BIPERIDEN HYDROCHLORIDE
AKINETON |
NDA | — |
|
PHENACEMIDE
PHENURONE |
NDA | — |
|
HYDROCODONE BITARTRATE, IBUPROFEN
VICOPROFEN |
NDA | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Amyotrophic Lateral Sclerosis, Chronic Kidney Disease, Chronic Low Back Pain, COVID-19, Disorder Related to Renal Transplantation, Endothelial Dysfunction, Growth Hormone-Deficiency, Healthy Volunteers, Insomnia, Myelodysplastic Syndromes, Osteoarthritis, Osteoarthritis |
|
TRANDOLAPRIL, VERAPAMIL HYDROCHLORIDE
TARKA |
NDA | — |
|
CARTEOLOL HYDROCHLORIDE
CARTROL |
NDA | Acute Disseminated Encephalomyelitis, Acute Myeloid Leukemia, Adenocarcinoma, Advanced Breast Cancer, Age Related Macular Degeneration, Age Related Macular Degeneration (AMD), Anti-AMPAR-1/2 Associated Autoimmune Encephalitis, Anti-CASPR-2 Associated Autoimmune Encephalitis, Anti-GABAR-1/2 Associated Autoimmune Encephalitis, Anti-GAD65 Associated Autoimmune Encephalitis, Anti-Lgi-1 Associated Autoimmune Encephalitis, Anti-NMDAR Encephalitis, Asthma, Breast Cancer, Breast Cancer Recurrent, Cancer, Carcinoma, Carcinoma, Renal Cell, Chronic Idiopathic Urticaria, Chronic Myeloid Leukemia, Chronic Spontaneous Urticaria, Chronic Urticaria, Clear-cell Metastatic Renal Cell Carcinoma, CNS Lupus, CNS Sarcoidosis, CNS Vasculitis, COVID-19, Ewing's Sarcoma, Failure of Exactly One Prior VEGF-targeted Therapy, Fallopian Tube Neoplasms, Hashimoto Encephalitis, HER 2 Negative Breast Cancer, Her2-negative Locally Advanced Breast Cancer, Her2-negative Metastatic Breast Cancer, HER2/Neu-negative Carcinoma of Breast, High-grade |
|
ATROPINE
ATROPINE |
NDA | — |
|
VALPROATE SODIUM
DEPACON |
NDA | — |
|
OMBITASVIR, PARITAPREVIR, RITONAVIR
TECHNIVIE |
NDA | — |
|
TRANDOLAPRIL
MAVIK |
NDA | — |
|
DESERPIDINE
HARMONYL |
NDA | — |
|
MEMANTINE HYDROCHLORIDE
NAMENDA |
NDA | — |
|
PROGESTERONE
CRINONE |
NDA | Acute Coronary Syndrome, Acute Coronary Syndromes, Anemia, Sickle Cell, Benign Prostatic Hyperplasia, Common Warts, Coronary Artery Disease, Coronary Artery Disease (CAD), COVID-19, Epithelial Ovarian Cancer, Healthy, Myocardial Infarction, Neoplasms, Pancreatic Cancer, SARS-CoV2 |
|
ACETAMINOPHEN, HYDROCODONE BITARTRATE
VICODIN HP |
NDA | Artificial Intelligence Mobile Application, Atherosclerosis, Carotid Artery Diseases, Coronary Artery Disease, End Stage Renal Disease, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Renal Failure |
|
ALCAFTADINE
LASTACAFT |
NDA | — |
|
OXYBUTYNIN
OXYTROL FOR WOMEN |
NDA | — |
|
PROTEIN HYDROLYSATE
AMINOSOL 5% |
NDA | — |
|
BIPERIDEN LACTATE
AKINETON |
NDA | — |
|
DASABUVIR SODIUM, OMBITASVIR, PARITAPREVIR, RITONAVIR
VIEKIRA XR |
NDA | ABBV-154, Abdominal Hernia, Absolute Bioavailability, Acne Scars, Acquired Immunodeficiency Syndrome, Acute Anterior Uveitis (AAU), Acute Biphenotypic Leukemia, Acute Kidney Injury, Acute Leukemia of Ambiguous Lineage, Acute Leukemia of Ambiguous Lineage in Relapse, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphocytic Leukemia (ALL), Acute Monocytic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia, in Relapse, Acute Pancreatitis, Acute Spinal Cord Injury (SCI), Addict Heroin, Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Prostate, Adenocarcinoma of the Rectum, Adjuvant Oral Zinc and Botulinum Toxin, Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin, Advanced Cancers, Advanced Colorectal Cancer, Advanced Hepatocellular Carcinoma, Advanced High-Grade Epithelial Ovarian Cancer, Advanced Idiopath |
|
METHARBITAL
GEMONIL |
NDA | — |
|
OXYBUTYNIN CHLORIDE
GELNIQUE |
NDA | 21-hydroxylase Deficiency, Achalasia, Acinetobacter Bacteremia, Acinetobacter Pneumonia, Acne, Acne Vulgaris, Acquired Immunodeficiency Syndrome, Acute Coronary Syndrome, Acute Myeloid Leukemia, Acute Pain, Acute Respiratory Infection, Adenomatous Polyps, Adnexal Diseases, Adolescent Behavior, Adult Skin Healthy Signs, Advance Care Planning, Advanced or Refractory Leukemia, Aged, Aging, AL Amyloidosis, Alcohol Abuse, Alcohol Dependence, Alcoholic Intoxication, Alcoholism, Allergic Rhinitis, Allergic Sensitization, Allergy, Allergy and Asthma, Alveolar Bone Loss, Alzheimer Disease, Alzheimer's Disease, Ametropia, Amyloidosis, Analgesics, Anastomotic Leak, Androgenetic Alopecia, Anemia, Ankle Arthritis, Ankle Dislocation, Ankle Fractures, Anxiety, Apathy, Appendicitis, Arrhythmias, Cardiac, Arthralgia, Asthma, Asthma in Children, Astigmatism, Atherosclerosis, Athlete's Foot, Atopic Dermatitis, Atopic Dermatitis (AD), Atrial Fibrillation, Atrial Flutter, Attention Deficit Hyperactivity Disorder, Attenuation of B |
|
SILODOSIN
RAPAFLO |
NDA | — |
|
EFLORNITHINE HYDROCHLORIDE
VANIQA |
NDA | — |
|
CHOLINE FENOFIBRATE
TRILIPIX |
NDA | — |
|
IOPAMIDOL
IOPAMIDOL-300 |
NDA | — |
|
MIVACURIUM CHLORIDE
MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER |
NDA | — |
|
HEXOCYCLIUM METHYLSULFATE
TRAL |
NDA | — |
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-10-01 | Phase2 Readout | — |
| 2027-01-01 | Phase1 Readout | — |
| 2027-02-28 | Phase2 Readout | — |
| 2027-06-01 | Phase2 Readout | — |
| 2027-07-01 | Phase3 Readout | — |
Active Clinical Trials (8)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT04401748 | Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Pa... | PHASE3 | Active Not Recruiting | 531 |
| NCT07007052 | Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Bl... | PHASE2 | Recruiting | 33 |
| NCT07024706 | Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2... | PHASE2 | Recruiting | 80 |
| NCT02899052 | Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multip... | PHASE2 | Active Not Recruiting | 120 |
| NCT06522386 | GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Pre... | PHASE2 | Active Not Recruiting | 50 |
| NCT03832361 | Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer | PHASE2 | Recruiting | 50 |
| NCT03709758 | Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML | PHASE1 | Active Not Recruiting | 50 |
| NCT02942290 | A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodys... | PHASE1 | Active Not Recruiting | 129 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.
FDA-Related SEC Filings
| Date | Type | Description | Link |
|---|---|---|---|
| 2026-06-22 | 8-K | AbbVie Inc. (ABBV) (CIK 0001551152) - EXHIBIT 99.2 | EDGAR |